Senestech (NASDAQ:SNES) Major Shareholder Acquires $328,020.00 in Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management bought 426,000 shares of Senestech stock in a transaction that occurred on Thursday, October 15th. The shares were bought at an average cost of $0.77 per share, with a total value of $328,020.00. Following the acquisition, the insider directly owned 1,505,294 shares in the company, valued at $1,159,076.38. This trade represents a 39.47% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Monday, October 19th, Glenbrook Capital Management purchased 376,552 shares of Senestech stock. The stock was bought at an average price of $0.70 per share, for a total transaction of $263,586.40.
• On Friday, October 16th, Glenbrook Capital Management acquired 181,252 shares of Senestech stock. The shares were bought at an average price of $0.63 per share, with a total value of $114,188.76.
• On Friday, August 7th, Glenbrook Capital Management acquired 6,490 shares of Senestech stock. The shares were purchased at an average price of $1.30 per share, with a total value of $8,437.00.
• On Thursday, August 6th, Glenbrook Capital Management bought 15,000 shares of Senestech stock. The stock was purchased at an average cost of $1.30 per share, for a total transaction of $19,500.00.

Senestech Stock Performance

Shares of Senestech stock traded up $0.05 on Monday, hitting $0.70. The stock had a trading volume of 1,245,150 shares, compared to its average volume of 375,681. The stock has a market cap of $3.79 million, a price-to-earnings ratio of -0.51 and a beta of 0.25. The company has a quick ratio of 5.81, a current ratio of 6.78 and a debt-to-equity ratio of 0.02. Senestech, Inc. has a twelve month low of $0.55 and a twelve month high of $4.04. The business’s 50 day moving average is $0.93 and its two-hundred day moving average is $1.34.

Senestech (NASDAQ:SNES) last released its quarterly earnings results on Wednesday, August 5th. The company reported ($0.35) earnings per share for the quarter, topping the consensus estimate of ($0.37) by $0.02. The business had revenue of $0.77 million during the quarter, compared to analysts’ expectations of $0.60 million. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%. Analysts forecast that Senestech, Inc. will post -1.28 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut shares of Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, August 11th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Senestech presently has an average rating of “Sell”.

Institutional Investors Weigh In On Senestech

An institutional investor recently bought a new stake in Senestech stock. Diversify Wealth Management LLC purchased a new stake in Senestech, Inc. (NASDAQ:SNES) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned 0.36% of Senestech at the end of the most recent quarter. 5.19% of the stock is currently owned by hedge funds and other institutional investors.

About Senestech

SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company’s approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.

SenesTech’s primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.